Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge 1
, 2 , 3 , 4 – 5 . Here we conducted a genome-wide association study (GWAS) involving 2,393 …

Coronavirus disease 2019 (COVID-19) is a recently-emerged infectious disease that has
caused millions of deaths, where comprehensive understanding of disease mechanisms is still …

Molnupiravir (MOV) and nirmatrelvir/ritonavir (NMV/r) are efficacious oral antiviral agents for
patients with the 2019 coronavirus (COVID-19). However, little is known about their …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread
worldwide and coronavirus disease 2019 remains a major health concern. Several SARS-CoV-2 …

Background A better understanding of the tumor immune microenvironment (TIME) will
facilitate the development of prognostic biomarkers and more effective therapeutic strategies in …

Background Therapeutic strategies in patients with interstitial pneumonia with autoimmune
features (IPAF) and histological usual interstitial pneumonia (UIP) pattern (IPAF-UIP) have …

To elucidate the host genetic loci affecting severity of SARS-CoV-2 infection, or Coronavirus
disease 2019 (COVID-19), is an emerging issue in the face of the current devastating …

Background Idiopathic pulmonary fibrosis (IPF) is characterised by worsening dyspnoea
and exercise intolerance. Research question Does a long-term pulmonary rehabilitation …

Introduction Monoclonal antibody therapy has been reported to be highly effective for
preventing hospitalisation and severe cases in patients with Coronavirus Disease 2019 (COVID-19…

Background Anti-glycyl-tRNA synthetase (anti-EJ) antibody is occasionally positive in
patients with interstitial lung disease (ILD). We aimed to define the clinical, radiological and …